Genetech Inc remains confident able U.S. Food Drug Adminstration obtain approval tissue plasminogen activator Activase treat heart attack victims. On Friday advisory committee FDA recommend blood clot dissolve drug approve additional mortality data developed. Genetech provide additional data believe already developed. Reuter 